Robert Schreiber
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
University Of Wasington School Of Medicine
Norway
Biography
Robert D. Schreiber, Ph.D is The Andrew M. and Jane M. Bursky Distinguished Professor in the Department of Pathology and Immunology at Washington University School of Medicine in St. Louis. He is co-leader of the Tumor Immunology Program of Washington University’s Siteman Comprehensive Cancer Center, and the Founding Director of the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. Schreiber is an Extramural Member Researcher of the Parker Institute for Cancer Immunotherapy, an Associate Director of the Scientific Advisory Board to the Cancer Research Institute, and a member of the Board of Scientific Advisors to the National Cancer Institute. Schreiber is a co-founder of three biotech companies: Igenica Biotherapeutics, Inc. (Burlingame CA), Jounce Therapeutics (Boston MA), and Neon Therapeutics, Inc (Cambridge, MA). Robert D. Schreiber, Ph.D is The Andrew M. and Jane M. Bursky Distinguished Professor in the Department of Pathology and Immunology at Washington University School of Medicine in St. Louis. He is co-leader of the Tumor Immunology Program of Washington University’s Siteman Comprehensive Cancer Center, and the Founding Director of the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. Schreiber is an Extramural Member Researcher of the Parker Institute for Cancer Immunotherapy, an Associate Director of the Scientific Advisory Board to the Cancer Research Institute, and a member of the Board of Scientific Advisors to the National Cancer Institute. Schreiber is a co-founder of three biotech companies: Igenica Biotherapeutics, Inc. (Burlingame CA), Jounce Therapeutics (Boston MA), and Neon Therapeutics, Inc (Cambridge, MA).
Research Interest
Robert Schreiber has authored more than 300 peer reviewed and invited publications and has received many honors including the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology from the Cancer Research Institute, the Charles Rodolphe Brupbacher Prize for Cancer Research, and the Lloyd J. Old Prize in Cancer Immunology awarded jointly by the American Association for Cancer Research and the Cancer Research Institute. Schreiber is a Fellow of the American Association for the Advancement of Science, a member of the American Academy of Arts and Sciences and a member of the U.S. National Academy of Sciences.